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 News Archive
RWU Alumni Launch a New Way to Wage the Fight Against
Malaria
With a new method to make antimalarial medication and a plan to bring production into
a single facility, their company hopes to meet one-third of global demand for medicine
within three years
Adam Maust '05 stands in the  rst  eld of artemisia
grown by the University of Kentucky. ArtemiFlow, a
company co-founded by fellow Hawk Kerry Gilmore
'06 and led by Maust as CEO, will begin growing and
producing the antimalarial medication. Photos
courtesy of ArtemiFlow
January 30, 2019 By Jill Rodrigues '05
LEXINGTON, K.Y. – For two Roger Williams University alumni, seeing the  rst thriving crops of the sweet wormwood
plant in the  elds of Kentucky represent seeds of hope that their company’s new method of producing antimalarial
medicine will revolutionize the  ght against malaria.
Malaria continues to be a global health crisis, killing nearly 500,000 people a year with two-thirds of those deaths in
children under the age of 5, according to the World Health Organization. Millions are infected each year, primarily in
Africa and Asia, but the disease is highly treatable and can be cured with medicines such as artemisinin-based
combination therapies. The problem is that not enough of the medicine is produced to meet the global demand.
Kerry Gilmore ’06, along with his fellow researcher Peter Seeberger, recently developed a groundbreaking method
to produce twice the amount of high-quality artemisinin from each sweet wormwood plant (Artemisia annua), the
main ingredient in the gold-standard treatment for malaria. With their patented chemistry breakthrough, they plan to
also break ground on a new way of producing the antimalarial medicine and bringing it to market with their company
ArtemiFlow USA. In January, they hired Gilmore’s good friend and fellow Hawk Adam Maust ’05 as corporate
executive o cer to establish the company in the United States.
“There are only two ways to  x the problem: inject more money into the system and buy more medicine that is out
there, or produce these medications more cheaply and e ciently – and that’s what we’re going to do on a larger
scale,” said Gilmore, who holds bachelor degrees in chemistry and biology from RWU and a doctorate in organic
chemistry from Florida State University.
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Because the plant is mostly grown on small farms in Vietnam and China, Gilmore says the current process goes
through several middlemen before it gets to the market, contributing to higher costs for those who need it and the
prevalence of scammers selling fake malaria medicine on the black market. That’s why their plan is to consolidate
production of antimalarial medicine, from farming to extraction and creating the pharmaceutical, into a single facility.
To test whether artemisinin would grow on United States soil, ArtemiFlow partnered with the University of Kentucky
to conduct a  eld study and successfully yielded a  rst crop late last year. With that favorable outcome, they are now
moving forward with  nding a location to build a facility in the region.
“The intention is that from plant to pill, all can be done in one place now, which drastically reduces the cost of making
the medicine,” said Maust, who holds a bachelor degree in political science from RWU. “And with us being able to
extract more medicine out of the plant at the highest (FDA) standard, we will be able to exceed the amount of
medicine the World Health Organization needs to  ght malaria.”
Kerry Gilmore '06 (right) and Peter Seeberger in their chemistry laboratory.
Over the past six years, Gilmore and Seeberger worked together in Germany’s Max Planck Institute of Colloids and
Interfaces to re ne their technique for extracting artemisinin, enabling them to derive it from the plant as well as from
the plant waste created during production. Their new method generates twice the volume of artemisinin than any
previous technique, and it’s a more e cient and low-cost production.
“We’ve streamlined the chemistry side of things with our extraction process, so what we’re able to do now is produce
the medication cheaper than anyone else in the world because we will have the entire supply chain in one place and
we can do everything more e ciently,” Gilmore said. “It will allow us to truly industrialize how this medicine is
produced and have an impact on the people who need this medication. There’s no reason anyone should die from
this disease. We just need more medication.”
The RWU Connection
They had a vision and groundbreaking science, but their mission wouldn’t have le  the ground without Maust and
Gilmore’s connection to RWU and to each other.
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Both say their hands-on educational experiences and multiple opportunities to conduct research prepared them well
for successful careers – Maust as political director of the Pennsylvania House Republican Campaign Committee and
partner at Red Maverick Media, and Gilmore as a Fulbright Scholar, chemist and assistant professor at the Max Planck
Institute of Colloids and Interfaces.
Maust credited RWU with giving him “the tools to be very successful at a young age,” from classes that developed his
critical thinking and foundational skills for a career in politics to getting his  rst taste of working on campaigns.
Gilmore said the opportunity to conduct undergraduate research both in chemistry and biotechnology, as well as
present research at national conferences and make connections to eminent scientists, helped launch his path into
graduate school and to work at a prestigious research institute.
But they didn’t have any of the same classes and their professional paths might have never crossed, if they hadn’t met
and become best friends at Roger Williams, playing on the ultimate Frisbee club, acting in comedy skits at the Barn,
and working a summer together as Orientation Advisers. They’ve remained close since graduation, traveling to see
each other around the world and o en talking about their work.
The  rst crop of artemisia growing in
Kentucky.
One day while Maust was visiting in Germany, Gilmore and Seeberger were discussing where in the world the
wormwood plant could grow beyond Southeast Asia. Maust looked at their topographical maps and suggested
Kentucky, knowing the terrain well from his career focused on political work in that region.
At the time, Maust was working at Red Maverick Media and managing hundreds of state and federal political
campaigns throughout Kentucky, Pennsylvania, West Virginia and Ohio. His specialty was running caucuses, helping
large campaign committees run races throughout their state. Maust made some calls to members of the Kentucky
House of Representatives and connected ArtemiFlow with the University of Kentucky to begin  eld studies on the
sweet wormwood plant.
“They’d developed this wonderful patented technology, but not having the connections to easily call and get a voice
in these o ces I think is a gap that always exists between these worlds and o en why a lot of projects probably don’t
get o  the ground,” Maust said.
When the  rst  eld study yielded superior results, Gilmore and Seeberger knew they had a viable venture and asked
Maust to come on board as CEO in January.
“When we traveled to Kentucky for meetings and started to see this take shape, we realized this was going to grow
past the point of a couple of academics in a lab and that the wonderful impact we dreamed of was going to become
a reality,” Gilmore said. “When we brought Adam in, he brought an extra perspective and a kick of energy, along with
the vision and his connections to bring people together, to drive this forward.”
“Maust has proven to have the experience, ingenuity, and the relationships needed to lead ArtemiFlow from the
development stage into production at a massive scale,” Seeberger said.
2/13/2019 RWU Alumni Launch a New Way to Wage the Fight Against Malaria | Roger Williams University
https://www.rwu.edu/news/news-archive/rwu-alumni-launch-new-way-wage-fight-against-malaria 4/4
Growing Seeds of Hope
Their goal is ambitious: to meet one-third of the global demand for malaria medicine with their  rst batch, and to
continue to increase production from there.
What’s more, Gilmore says that artemisinin has been showing great promise in treating cancers, including breast
cancer, cervical cancer, and colorectal cancer, in pre-clinical trials. He says those studies have shown that artemisinin
 ghts these cancers without producing painful side e ects of chemotherapy, and it can eradicate cancer if it’s caught
early enough. Recognizing that potential, ArtemiFlow is partnering with the University of Kentucky’s Markey Cancer
Center to explore artemisinin’s potential to cure cancer in human trials starting this year.
As his  rst objective as CEO, Maust is identifying where to locate the company – looking at where the company will
have the most political support and local agricultural knowledge. He’s continuing to meet with farmers who will grow
the wormwood plants, in many cases in place of tobacco crops. It turns out that wormwood “grows in a similar
pattern of time as development as tobacco, which is what cued me up to look at the states I’m familiar with,” Maust
said.
It’s ironic, Maust added, that farmers who once grew a known cancer agent could wind up instead growing a cure for
cancer. But he says that it’s just part of the amazing story that ArtemiFlow will bring to life.
“The wild thing about this is that a political science guy who is best friends with a
scientist in Germany can connect with a farmer in Kentucky to create a product
that will save not only hundreds of thousands of lives in Africa, but potentially
millions more over its course with malaria and the potential for cancer,” Maust
said. “We have the opportunity to really put a mark on this world and the great
part is that there’s so many opportunities for people to put a mark on this
themselves.”
That seed of hope they grew with the  rst wormwood crops might yet yield the fruit of their dreams and become a
serious agent in the  ght against malaria and cancer.
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